Axon Enterprise, Inc $AXON Stake Raised by Citizens Financial Group Inc. RI

Citizens Financial Group Inc. RI grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 50.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 593 shares of the biotechnology company’s stock after purchasing an additional 198 shares during the period. Citizens Financial Group Inc. RI’s holdings in Axon Enterprise were worth $491,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. Hemington Wealth Management lifted its stake in Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 17 shares during the last quarter. Whipplewood Advisors LLC increased its holdings in shares of Axon Enterprise by 192.9% in the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after buying an additional 27 shares in the last quarter. NewSquare Capital LLC lifted its position in shares of Axon Enterprise by 96.2% during the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock valued at $42,000 after acquiring an additional 25 shares during the last quarter. Washington Trust Advisors Inc. boosted its stake in shares of Axon Enterprise by 44.7% during the 2nd quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock worth $46,000 after acquiring an additional 17 shares in the last quarter. Finally, TCTC Holdings LLC boosted its stake in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after acquiring an additional 24 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In related news, CFO Brittany Bagley sold 2,500 shares of Axon Enterprise stock in a transaction on Monday, November 10th. The stock was sold at an average price of $610.00, for a total transaction of $1,525,000.00. Following the completion of the sale, the chief financial officer owned 91,092 shares of the company’s stock, valued at approximately $55,566,120. This trade represents a 2.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Jennifer H. Mak sold 77 shares of Axon Enterprise stock in a transaction on Monday, September 15th. The shares were sold at an average price of $760.00, for a total value of $58,520.00. Following the sale, the chief accounting officer directly owned 15,003 shares of the company’s stock, valued at approximately $11,402,280. The trade was a 0.51% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 38,622 shares of company stock worth $26,439,364. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Down 1.7%

NASDAQ:AXON opened at $533.77 on Wednesday. The stock has a market cap of $42.12 billion, a PE ratio of 131.80, a price-to-earnings-growth ratio of 29.49 and a beta of 1.45. Axon Enterprise, Inc has a fifty-two week low of $469.24 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The stock’s 50-day moving average is $694.97 and its two-hundred day moving average is $734.66.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company had revenue of $710.64 million for the quarter, compared to analyst estimates of $704.83 million. During the same quarter in the prior year, the business posted $1.45 earnings per share. The business’s revenue for the quarter was up 30.6% compared to the same quarter last year. As a group, equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently commented on AXON shares. The Goldman Sachs Group reduced their target price on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a report on Thursday, November 13th. Piper Sandler reduced their price objective on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Bank of America raised their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Finally, Barclays cut their price target on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a report on Thursday, November 6th. Fifteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $814.00.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.